109 related articles for article (PubMed ID: 17001281)
1. Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's disease.
Phillips W; Morton AJ; Barker RA
Neuroreport; 2006 Oct; 17(15):1623-7. PubMed ID: 17001281
[TBL] [Abstract][Full Text] [Related]
2. Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment.
Lazic SE; Grote HE; Blakemore C; Hannan AJ; van Dellen A; Phillips W; Barker RA
Eur J Neurosci; 2006 Apr; 23(7):1829-38. PubMed ID: 16623840
[TBL] [Abstract][Full Text] [Related]
3. Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1.
Fedele V; Roybon L; Nordström U; Li JY; Brundin P
Neuroscience; 2011 Jan; 173():76-81. PubMed ID: 20807561
[TBL] [Abstract][Full Text] [Related]
4. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
[TBL] [Abstract][Full Text] [Related]
5. Olfactory abnormalities in Huntington's disease: decreased plasticity in the primary olfactory cortex of R6/1 transgenic mice and reduced olfactory discrimination in patients.
Lazic SE; Goodman AO; Grote HE; Blakemore C; Morton AJ; Hannan AJ; van Dellen A; Barker RA
Brain Res; 2007 Jun; 1151():219-26. PubMed ID: 17400200
[TBL] [Abstract][Full Text] [Related]
6. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
Gil JM; Mohapel P; Araújo IM; Popovic N; Li JY; Brundin P; Petersén A
Neurobiol Dis; 2005 Dec; 20(3):744-51. PubMed ID: 15951191
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment.
Phillips W; Morton AJ; Barker RA
J Neurosci; 2005 Dec; 25(50):11564-76. PubMed ID: 16354914
[TBL] [Abstract][Full Text] [Related]
8. Modeling brain reserve: experience-dependent neuronal plasticity in healthy and Huntington's disease transgenic mice.
Nithianantharajah J; Barkus C; Vijiaratnam N; Clement O; Hannan AJ
Am J Geriatr Psychiatry; 2009 Mar; 17(3):196-209. PubMed ID: 19454847
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
Petersén A; Chase K; Puschban Z; DiFiglia M; Brundin P; Aronin N
Exp Neurol; 2002 May; 175(1):297-300. PubMed ID: 12009780
[TBL] [Abstract][Full Text] [Related]
10. Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease.
Kohl Z; Kandasamy M; Winner B; Aigner R; Gross C; Couillard-Despres S; Bogdahn U; Aigner L; Winkler J
Brain Res; 2007 Jun; 1155():24-33. PubMed ID: 17512917
[TBL] [Abstract][Full Text] [Related]
11. Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.
Glynn D; Reim K; Brose N; Morton AJ
Brain Res Bull; 2007 Apr; 72(2-3):108-20. PubMed ID: 17352934
[TBL] [Abstract][Full Text] [Related]
12. A similar impairment in CA3 mossy fibre LTP in the R6/2 mouse model of Huntington's disease and in the complexin II knockout mouse.
Gibson HE; Reim K; Brose N; Morton AJ; Jones S
Eur J Neurosci; 2005 Oct; 22(7):1701-12. PubMed ID: 16197510
[TBL] [Abstract][Full Text] [Related]
13. Neurogenesis in Huntington's disease: can studying adult neurogenesis lead to the development of new therapeutic strategies?
Gil-Mohapel J; Simpson JM; Ghilan M; Christie BR
Brain Res; 2011 Aug; 1406():84-105. PubMed ID: 21742312
[TBL] [Abstract][Full Text] [Related]
14. Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease.
Josefsen K; Nielsen MD; Jørgensen KH; Bock T; Nørremølle A; Sørensen SA; Naver B; Hasholt L
J Neuroendocrinol; 2008 Feb; 20(2):165-72. PubMed ID: 18034868
[TBL] [Abstract][Full Text] [Related]
15. Seizures induce proliferation and dispersion of doublecortin-positive hippocampal progenitor cells.
Jessberger S; Römer B; Babu H; Kempermann G
Exp Neurol; 2005 Dec; 196(2):342-51. PubMed ID: 16168988
[TBL] [Abstract][Full Text] [Related]
16. Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.
André VM; Cepeda C; Venegas A; Gomez Y; Levine MS
J Neurophysiol; 2006 Apr; 95(4):2108-19. PubMed ID: 16381805
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
[TBL] [Abstract][Full Text] [Related]
18. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.
Rebec GV; Conroy SK; Barton SJ
Neuroscience; 2006; 137(1):327-36. PubMed ID: 16257492
[TBL] [Abstract][Full Text] [Related]
19. Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation.
Freeman W; Morton AJ
Brain Res Bull; 2004 Mar; 63(1):45-55. PubMed ID: 15121238
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between PSA-NCAM expression and migration in the rostral migratory stream of a Huntington's disease transgenic mouse model.
Moraes L; de Moraes Mello LE; Shimabukuro MK; de Castro Batista CM; Mendez-Otero R
Neuropathology; 2009 Apr; 29(2):140-7. PubMed ID: 18713310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
